Imperva to Present at Upcoming Investor Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Oppenheimer Raises Price Target on Imperva (IMPV) to $75 Ahead of 2Q15 Results
August 5, 2015 7:01 AM EDTOppenheimer reiterated an Outperform rating on Imperva (NYSE: IMPV), and raised the price target to $75.00 (from $58.00), ahead of 2Q15 results. Analyst Shaul Eyal believes IMPV saw solid demand across all product and geographic regions. Oppenheimer raised revenue/EPS estimates to $48.7M/($0.22) from $48.2M/($0.22), going above... More
